Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Isobel Sharpe, Meghan Bowman, Andrew Kim, Siddhartha Srivastava, Matthew Jalink & Don Thiwanka Wijeratne. (2021) Strategies to Prevent Readmissions to Hospital for COPD: A Systematic Review. COPD: Journal of Chronic Obstructive Pulmonary Disease 18:4, pages 456-468.
Read now
Read now
Brian W. Carlin, Sandra K. Schuldheisz, Imre Noth & Gerard J. Criner. (2017) Individualizing the selection of long-acting bronchodilator therapy for patients with COPD: considerations in primary care. Postgraduate Medicine 129:7, pages 725-733.
Read now
Read now
Vaidyanathan Ganapathy & Michael D Stensland. (2017) Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1793-1801.
Read now
Read now
Yaozhu J. Chen, Charles Makin, Vamsi K. Bollu, Maryam Navaie & Bartolome R. Celli. (2016) Exacerbations, health services utilization, and costs in commercially-insured COPD patients treated with nebulized long-acting 2-agonists. Journal of Medical Economics 19:1, pages 11-20.
Read now
Read now
Chee H Loh, James F Donohue & Jill A Ohar. (2015) Review of drug safety and efficacy of arformoterol in chronic obstructive pulmonary disease. Expert Opinion on Drug Safety 14:3, pages 463-472.
Read now
Read now
Articles from other publishers (14)
S.K. Katiyar, S.N. Gaur, R.N. Solanki, Nikhil Sarangdhar, J.C. Suri, Raj Kumar, G.C. Khilnani, Dhruva Chaudhary, Rupak Singla, Parvaiz A. Koul, Ashok A. Mahashur, A.G. Ghoshal, D. Behera, D.J. Christopher, Deepak Talwar, Dhiman Ganguly, H. Paramesh, K.B. Gupta, Mohan Kumar T, P.D. Motiani, P.S. Shankar, Rajesh Chawla, Randeep Guleria, S.K. Jindal, S.K. Luhadia, V.K. Arora, V.K. Vijayan, Abhishek Faye, Aditya Jindal, Amit K. Murar, Anand Jaiswal, Arunachalam M, A.K. Janmeja, Brijesh Prajapat, C. Ravindran, Debajyoti Bhattacharyya, George D'Souza, Inderpaul Singh Sehgal, J.K. Samaria, Jogesh Sarma, Lalit Singh, M.K. Sen, Mahendra K. Bainara, Mansi Gupta, Nilkanth T. Awad, Narayan Mishra, Naveed N. Shah, Neetu Jain, Prasanta R. Mohapatra, Parul Mrigpuri, Pawan Tiwari, R. Narasimhan, R. Vijai Kumar, Rajendra Prasad, Rajesh Swarnakar, Rakesh K. Chawla, Rohit Kumar, S. Chakrabarti, Sandeep Katiyar, Saurabh Mittal, Sonam Spalgais, Subhadeep Saha, Surya Kant, V.K. Singh, Vijay Hadda, Vikas Kumar, Virendra Singh, Vishal Chopra & Visweswaran B. (2022) Indian Guidelines on Nebulization Therapy. Indian Journal of Tuberculosis 69, pages S1-S191.
Crossref
Crossref
Lili Chen & Shiping Chen. (2021) Prediction of readmission in patients with acute exacerbation of chronic obstructive pulmonary disease within one year after treatment and discharge. BMC Pulmonary Medicine 21:1.
Crossref
Crossref
Fatma Tokgöz Akyıl, Seda Tural Önür, Hülya Abalı, Sinem Sökücü, Cengiz Özdemir, Neslihan Boyracı, Aslı Kocaoğlu & Sedat Altın. (2021) Hyponatremia is an independent predictor of emergency department revisits in acute exacerbation of COPD. The Clinical Respiratory Journal 15:10, pages 1063-1072.
Crossref
Crossref
Jaber S. Alqahtani, Chidiamara M. Njoku, Bonnie Bereznicki, Barbara C. Wimmer, Gregory M. Peterson, Leigh Kinsman, Yousef S. Aldabayan, Ahmed M. Alrajeh, Abdulelah M. Aldhahir, Swapna Mandal & John R. Hurst. (2020) Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis. European Respiratory Review 29:156, pages 190166.
Crossref
Crossref
Allison Keshishian, Lin Xie, Carole Dembek & Huseyin Yuce. (2019) Reduction in Hospital Readmission Rates Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease: A Real-world Outcomes Study of Nebulized Bronchodilators. Clinical Therapeutics 41:11, pages 2283-2296.
Crossref
Crossref
Sarah E. Petite & Julie A. Murphy. (2018) Evaluation of Bronchodilator Use During Chronic Obstructive Pulmonary Disease Exacerbation Inpatient Admissions. Hospital Pharmacy 54:2, pages 112-118.
Crossref
Crossref
Alpesh N. Amin, Vamsi Bollu, Michael D. Stensland, Logan Netzer & Vaidyanathan Ganapathy. (2018) Treatment patterns for patients hospitalized with chronic obstructive pulmonary disease. American Journal of Health-System Pharmacy 75:6, pages 359-366.
Crossref
Crossref
Meenakshi Patel, Karl Steinberg, Manuel Suarez-Barcelo, Dana Saffel, Rick Foley & Chad Worz. (2017) Chronic Obstructive Pulmonary Disease in Post-acute/Long-term Care Settings: Seizing Opportunities to Individualize Treatment and Device Selection. Journal of the American Medical Directors Association 18:6, pages 553.e17-553.e22.
Crossref
Crossref
Vamsi Bollu, Annie Guérin, Geneviève Gauthier, Robert Hiscock & Eric Q. Wu. (2016) Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized β2-Agonists. Drugs - Real World Outcomes 4:1, pages 33-41.
Crossref
Crossref
Deepa Raghavan, Thaddeus Bartter & Manish Joshi. (2016) How to reduce hospital readmissions in chronic obstructive pulmonary disease?. Current Opinion in Pulmonary Medicine 22:2, pages 106-112.
Crossref
Crossref
Anand S. Iyer, Surya P. Bhatt, Jeffrey J. Garner, J. Michael Wells, Jennifer L. Trevor, Neha M. Patel, deNay Kirkpatrick, John C. Williams & Mark T. Dransfield. (2016) Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society 13:2, pages 197-203.
Crossref
Crossref
John N. Pritchard. (2015) Rethinking the paradigm for the development of inhaled drugs. International Journal of Pharmaceutics 496:2, pages 1069-1072.
Crossref
Crossref
Peter K. Lindenauer, Meng-Shiou Shieh, Penelope S. Pekow & Mihaela S. Stefan. (2014) Use and Outcomes Associated with Long-acting Bronchodilators among Patients Hospitalized for Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society 11:8, pages 1186-1194.
Crossref
Crossref
Junying Ding & Qingquan Liu. (2014) Research Advance in the Efficacy and Mechanism of Qing Fei Xiao Yan Wan for the Treatment of Respiratory Diseases. Modern Research in Inflammation 03:03, pages 113-121.
Crossref
Crossref